Home > Quotes > AMRN

Amarin Corporation plc Quote & Summary Data

Get AMRN Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading AMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Amarin Corporation plc Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 1.89 $ 2.80
Low $ 1.82 $ 1.24

The current last sale of $1.83 is 47.58% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Amarin is a clinical-stage biopharmaceutical company with a lead program entering Phase 3 for hypertriglyceridemia. Amarin's cardiovascular programs capitalize on its expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular disease. Amarin's pipeline also includes programs in myasthenia gravis, Huntington's disease, Parkinson's disease and epilepsy, all of which are available for partnering. Amarin is listed in the U.S. on the NASDAQ Capital Market ("AMRN"). For more information please visit www.amarincorp.com.  ... More ...  

Risk Grade

Where does AMRN fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?